Treating high-risk people with a rheumatoid arthritis drug could help delay the condition's onset by up to 4 years, new research suggests.
People receiving a year of abatacept (Orencia) injections had onset of rheumatoid arthritis postponed by up to four years, ...
Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...
Everyday Health on MSN
Hydrotherapy for rheumatoid arthritis
Water-based therapies can help with joint stiffness, pain, and limited mobility, offering relaxation and low-impact exercise.
Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...
NEW YORK — Patients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated to manage that risk. Rheumatologists ...
In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.
You can reduce osteoporosis risk with RA and care for bone health through effective treatments, lifestyle changes, and proper ...
Cedars-Sinai’s center provides personalized, multidisciplinary care for RA and related conditions, improving patient outcomes and quality of life. Dr. Jon Giles' research explores autoimmune disease ...
Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of neuronal activity patterns. This study sought to determine whether neural ...
MILAN — Treatment of rheumatoid arthritis (RA) with tumor necrosis factor inhibitors (TNFi) does not appear to demonstrate a consistent and significant risk for demyelinating disease, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results